Page last updated: 2024-10-31

metyrapone and Skin Diseases

metyrapone has been researched along with Skin Diseases in 3 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bartley, PC1
James, VH1
Munro, DD1
Feiwel, M1
Ferrari, E1
Bossolo, PA1
Pallavicini, S1
Personeni, G1

Reviews

1 review available for metyrapone and Skin Diseases

ArticleYear
Topical steroids and hypothalamo-pituitary-adrenal suppression: a review.
    The Australasian journal of dermatology, 1978, Volume: 19, Issue:3

    Topics: Administration, Topical; Adrenal Cortex Hormones; Circadian Rhythm; Cushing Syndrome; Humans; Hypoth

1978

Other Studies

2 other studies available for metyrapone and Skin Diseases

ArticleYear
Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate.
    Lancet (London, England), 1967, Nov-18, Volume: 2, Issue:7525

    Topics: 17-Hydroxycorticosteroids; Adult; Aged; Betamethasone; Female; Humans; Male; Metyrapone; Middle Aged

1967
[Corticotropo-corticoadrenal dynamics in prolonged cortisone treatment].
    Folia endocrinologica, 1967, Volume: 20, Issue:5

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotr

1967